|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.00 GBX | +0.10% |
|
-1.31% | +3.16% |
| 12/02 | Who is Sanofi's new CEO Belén Garijo? | RE |
| 05/02 | Syncona hails biotech recovery ahead of dividend policy vote | AN |
Business description: Syncona Limited
Number of employees: 1,215
Sales by Activity: Syncona Limited
| Fiscal Period: March | 2021 (GBP) | 2022 (GBP) | 2023 (GBP) | 2024 (GBP) | 2025 (GBP) |
|---|---|---|---|---|---|
Financial Services - Closed End Funds | 7.85Cr | 1.87Cr | -3.98Cr | 3.07Cr | -12Cr |
Executive Committee: Syncona Limited
| Manager | Title | Age | Since |
|---|---|---|---|
John Tsai
PRN | Corporate Officer/Principal | 59 | 01/01/2023 |
Composition of the Board of Directors: Syncona Limited
| Director | Title | Age | Since |
|---|---|---|---|
Gian Reverberi
BRD | Director/Board Member | 60 | 01/04/2018 |
Melanie Gee
CHM | Chairman | 65 | 04/06/2019 |
Kemal Malik
BRD | Director/Board Member | 63 | 15/06/2020 |
| Director/Board Member | 68 | 01/02/2022 | |
John Roche
BRD | Director/Board Member | - | 01/10/2024 |
Company details: Syncona Limited
Group companies: Syncona Limited
| Name | Category and Sector |
|---|---|
Biotechnology
| |
Biotechnology
|
Other Holding Companies
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.10% | -1.31% | +13.29% | -35.36% | 80Cr | |
| -0.21% | -1.41% | +30.45% | +71.94% | 12TCr | |
| -0.20% | -0.78% | +45.65% | +75.51% | 2.29TCr | |
| -0.60% | -2.01% | +34.20% | +36.86% | 1.74TCr | |
| +0.09% | -1.94% | +9.20% | +16.01% | 1.39TCr | |
| +6.03% | -6.18% | +67.29% | +84.87% | 1.34TCr | |
| -0.57% | -3.55% | -25.89% | -14.69% | 1.29TCr | |
| -1.63% | -3.25% | -31.44% | +46.00% | 1.17TCr | |
| -2.03% | -0.09% | -5.86% | +137.40% | 1.19TCr | |
| +0.85% | +1.74% | +10.51% | +35.70% | 1.16TCr | |
| Average | +0.30% | -2.42% | +14.74% | +45.42% | 2.38TCr | |
| Weighted average by Cap. | +0.13% | -1.54% | +24.08% | +62.35% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SYNC Stock
- Company Syncona Limited
Select your edition
All financial news and data tailored to specific country editions
